14
Jan
2020
17:00
GMT
Webinar
Optimizing Cryoballoon Ablation: Patient Tailored AF Treatment With Arctic Front Advance Pro™
-
Views:
619
-
Likes:
1
Overview
Experts in electrophysiology will showcase the science and evidence behind the 4th generation Arctic Front Advance Pro™ cardiac cryoablation catheter and highlight the latest clinical evidence. The presenters will each draw on their clinical experience, for an in-depth discussion on improvements made in cryoballoon AF ablation and share practical advice to tailor the procedure to the individual patient.
The first Arctic Front™ cardiac cryoablation procedure took place in 2005, and since then, over 500,000 patients have been treated with the Arctic Front™ family of cardiac cryoablation catheters in over 1,600 centers worldwide.1 The efficiency benefits of this unique single-shot therapy are obvious and well documented in more than 800 peer-reviewed scientific articles. The results of the landmark FIRE AND ICE and CRYO4PERSISTENT AF trials highlight an important global shift to value-based healthcare, measured by the ability to standardize the index PVI procedure. The impact on patient outcomes as well as the economic value for the global healthcare systems is significant.
Faculty:

Andreas Metzner

Serge Boveda

Tarv Dhanjal
This webinar is supported by

Key Learning Objectives
- improvements made with the 4th generation Arctic Front Advance Pro™ cardiac cryoablation catheter and latest clinical data.
- updates on dosing protocols to tailor AF ablation to the individual patient (vein).
- tips and techniques to improve visualization of time-to-isolation (TTI).
Target Audience
- Cardiac electrophysiologists and allied health professionals performing and assisting during cryoballoon AF ablation procedures.
- Healthcare professionals using alternative AF ablation techniques.
- Referring healthcare professionals treating AF patients will also find this topical.
Faculty Biographies

Andreas Metzner
Dr. Metzner has been a Senior physician (Oberarzt) at the cardiac electrophysiology department at the Asklepios Klinik St. Georg in Hamburg, Germany, since 2013. He and his colleagues, under the leadership of Prof.

Serge Boveda
Prof Dr Serge Boveda, Clinique Pasteur, Toulouse, FRProf Dr Boveda (MD, PhD, FESC, FEHRA) is a specialist in cardiovascular diseases and the interventional treatment of cardiac arrhythmias since 1994.

Tarv Dhanjal
Dr Tarv Dhanjal, University Hospital Coventry & Warwickshire, NHS Trust, UKDr.